Literature DB >> 12468674

The "ecstasy" hangover: hyponatremia due to 3,4-methylenedioxymethamphetamine.

Stephen J Traub1, Robert S Hoffman, Lewis S Nelson.   

Abstract

3,4-Methylenedioxymethamphetamine (MDMA, or "ecstasy") has gained an undeserved reputation as a "safe" drug among its users. However, hyperthermia, rhabdomyolysis, hepatotoxicity, disseminated intravascular coagulation, long-term serotonergic neurotoxicity, and death are all associated with MDMA use. Hyponatremia is also reported, and its manifestations are frequently delayed several hours after the drug is ingested. The etiology of this hyponatremia is unclear; both the syndrome of inappropriate antidiuretic hormone release (SIADH) and free-water intoxication are advanced as explanations. We describe a 19-year-old female who presented to the emergency department with altered mental status 1 day after using MDMA. Her initial serum sodium was 121 mmol/L, and computerized tomography (CT) of her head demonstrated cerebral edema. She was treated with hypertonic saline and fluid restriction, and her serum sodium increased to 132 mmol/L over the next 24 hours. She regained consciousness completely within 48 hours of presentation and recovered uneventfully. MDMA toxicity, particularly the pathophysiology and treatment of MDMA-induced hyponatremia, are discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12468674      PMCID: PMC3456731          DOI: 10.1093/jurban/79.4.549

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  34 in total

Review 1.  Selective serotonin reuptake inhibitors and hyponatraemia: review and proposed mechanisms in the elderly.

Authors:  V Kirchner; L E Silver; C A Kelly
Journal:  J Psychopharmacol       Date:  1998       Impact factor: 4.153

2.  Severe hyponatremia and inappropriate antidiuretic hormone secretion following ecstasy use.

Authors:  I Ajaelo; K Koenig; E Snoey
Journal:  Acad Emerg Med       Date:  1998-08       Impact factor: 3.451

3.  Hyponatraemia, seizures and stupor associated with ecstasy ingestion in a female.

Authors:  C Magee; H Staunton; W Tormey; J J Walshe
Journal:  Ir Med J       Date:  1998 Oct-Nov

4.  Hyponatraemic coma after ecstasy ingestion.

Authors:  X Nuvials; J R Masclans; R Peracaula; F J de Latorre
Journal:  Intensive Care Med       Date:  1997-04       Impact factor: 17.440

5.  Mood and cognitive effects of +/-3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): week-end 'high' followed by mid-week low.

Authors:  H V Curran; R A Travill
Journal:  Addiction       Date:  1997-07       Impact factor: 6.526

6.  Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans.

Authors:  M Mas; M Farré; R de la Torre; P N Roset; J Ortuño; J Segura; J Camí
Journal:  J Pharmacol Exp Ther       Date:  1999-07       Impact factor: 4.030

7.  Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study.

Authors:  U D McCann; M Mertl; V Eligulashvili; G A Ricaurte
Journal:  Psychopharmacology (Berl)       Date:  1999-04       Impact factor: 4.530

8.  Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/-)3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery.

Authors:  G Hatzidimitriou; U D McCann; G A Ricaurte
Journal:  J Neurosci       Date:  1999-06-15       Impact factor: 6.167

9.  Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

Authors:  U D McCann; Z Szabo; U Scheffel; R F Dannals; G A Ricaurte
Journal:  Lancet       Date:  1998-10-31       Impact factor: 79.321

10.  Ecstasy: a common cause of severe acute hepatotoxicity.

Authors:  V Andreu; A Mas; M Bruguera; J M Salmerón; V Moreno; S Nogué; J Rodés
Journal:  J Hepatol       Date:  1998-09       Impact factor: 25.083

View more
  11 in total

Review 1.  Postmortem diagnosis of hyponatremia: case report and literature review.

Authors:  Jessica Vanhaebost; Cristian Palmiere; Maria Pia Scarpelli; Fabiola Bou Abdallah; Arnaud Capron; Gregory Schmit
Journal:  Int J Legal Med       Date:  2017-05-13       Impact factor: 2.686

Review 2.  The neural basis of homeostatic and anticipatory thirst.

Authors:  Claire Gizowski; Charles W Bourque
Journal:  Nat Rev Nephrol       Date:  2017-11-13       Impact factor: 28.314

3.  H2O coma.

Authors:  Dorothea Stiefel; Axel Petzold
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

Review 4.  Hyponatremia at autopsy: an analysis of etiologic mechanisms and their possible significance.

Authors:  Angela Byramji; Glenda Cains; John D Gilbert; Roger W Byard
Journal:  Forensic Sci Med Pathol       Date:  2008-06-12       Impact factor: 2.007

5.  Diabetic ketoacidosis complicated by the use of ecstasy: a case report.

Authors:  Mirnaluci Paulino Ribeiro Gama; Bárbara Vicente de Souza; Ana Carolina Ossowski; Rafaela Cristina Perraro
Journal:  J Med Case Rep       Date:  2010-08-03

Review 6.  Rhabdomyolysis.

Authors:  W H Bagley; H Yang; K H Shah
Journal:  Intern Emerg Med       Date:  2007-10-01       Impact factor: 3.397

7.  Chronic exposure to MDMA (Ecstasy) elicits behavioral sensitization in rats but fails to induce cross-sensitization to other psychostimulants.

Authors:  Gunjan M Modi; Pamela B Yang; Alan C Swann; Nachum Dafny
Journal:  Behav Brain Funct       Date:  2006-01-04       Impact factor: 3.759

8.  A Case of MDMA-Associated Cerebral and Pulmonary Edema Requiring ECMO.

Authors:  A Thakkar; K Parekh; K El Hachem; E M Mohanraj
Journal:  Case Rep Crit Care       Date:  2017-11-15

9.  Methylenedioxymethamphetamine (MDMA)-Induced Hyponatremia: Case Report and Literature Review.

Authors:  Sherif Elkattawy; Ahmed Mowafy; Islam Younes; Marina Tucktuck; James Agresti
Journal:  Cureus       Date:  2021-05-25

10.  Ecstasy induces reactive oxygen species, kidney water absorption and rhabdomyolysis in normal rats. Effect of N-acetylcysteine and Allopurinol in oxidative stress and muscle fiber damage.

Authors:  Ana C de Bragança; Regina L M Moreau; Thales de Brito; Maria H M Shimizu; Daniele Canale; Denise A de Jesus; Ana M G Silva; Pedro H Gois; Antonio C Seguro; Antonio J Magaldi
Journal:  PLoS One       Date:  2017-07-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.